Does controlled ovarian hyperstimulation in women with a history of endometriosis influence recurrence rate?

Maria Elisabetta Coccia, Coccia ME, Rizzello F, Francesca Rizzello, Gianfranco Scarselli, Gianfranco S, Scarselli Gianfranco
Journal of women's health (2002) · 2010 · vol. 19(11) , pp. 2063–2069 · doi:10.1089/jwh.2009.1914 · PMID:20831441 · W2072892930
Observational OA: green CC0 ⤵ 29 in-corpus citations
🔓 Open OA copy View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-07 ⓘ

Controlled ovarian hyperstimulation for assisted reproductive technology did not increase endometriosis recurrence rates compared to a control group, suggesting gonadotropin treatments do not alter endometriotic lesion progression.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

BACKGROUND: Endometriosis is a common estrogen-dependent disease. The aim of this study was to assess whether controlled ovarian hyperstimulation (COH) for assisted reproductive technology (ART) was associated with an increased incidence in endometriosis recurrence as documented by transvaginal ultrasound (TV-US). METHODS: In a retrospective cohort study of 592 patients submitted to laparoscopy for endometriosis, 177 with infertility-related endometriosis who underwent a periodic ultrasound follow-up after laparoscopy were selected. Women who started ART after laparoscopy (n = 90) were compared with the control group, who did not undergo ART (n = 87). Recurrence of endometriosis was defined as the presence of endometriotic lesions observed through TV-US. RESULTS: During a long-term TV-US follow-up (1-15 years), 40 (22.6%) recurrences were observed. Patients submitted to ART showed a cumulative recurrence rate similar to that of the control group (28.6% and 37.9% respectively, p = 0.471). Recurrent lesions were ovarian cysts (47.5%), ovarian nodules (37.5%), and rectovaginal disease (15%). The stratified analysis based on stages of endometriosis and pelvic pain did not show differences. CONCLUSIONS: Gonadotropin treatments do not seem to affect the natural history of endometriotic lesions. The most important prognostic factors in recurrent disease observed by TV-US seem to be the stage of endometriosis and the presence of pelvic pain at the time of the first laparoscopic treatment.

My notes (saved in your browser only)

Condition tags

endometriosisinfertility

MeSH descriptors

Chorionic Gonadotropin Endometriosis Infertility, Female Ovulation Induction Adult Adult Chorionic Gonadotropin Chorionic Gonadotropin Chorionic Gonadotropin Cohort Studies Cohort Studies Endometriosis Endometriosis Endometriosis Female Female Follicle Stimulating Hormone Follicle Stimulating Hormone Follicle Stimulating Hormone Follow-Up Studies

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (23)

Cited by (29)

Source provenance

europepmc
last seen: 2026-10-10T06:11:15.153948+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:08:04.945943+00:00
License: CC0 · commercial use OK